Date: June 28, 2023
Time: 11:00am PDT, 12:00pm MDT, 1:00pm CDT, 2:00pm EDT
Webinar airing too early or too late for you?
The human genome project was undertaken to determine the human DNA sequence and analyze variation among individuals. To make use of this information, tools were developed that could collect and analyze all the sequence information being generated. DNA microarray analysis is a major platform for these studies, since hundreds of thousands of defined sequences can be queried at one time. The Applied Biosystems Axiom® SNP microarrays incorporate the latest innovations in bioinformatics, fabrication and chemistries into a gold-standard analytical platform. It is the microarray of choice for population-based polygenic risk analysis, dissecting patterns of inheritance, and pharmacogenomics. In this talk, we will discuss how the Axiom family of microarrays are being used by researchers and governmental biobank organizations for these studies.
Learning Objectives
- Understand how microarrays have been instrumental in human genomic analyses
- Understand how the Axiom advancements have led to increased efficiency
- Understand the types of research that are facilitated by microarrays
- Understand how microarrays are used by governmental biobanking for predictive genomics
- Understand how microarrays and predictive genomics aid pharmacogenomic analyses, and the benefits of pharmacogenomics
Who should attend?
- Laboratory directors
- Laboratory managers
- Principal investigators
- Pathologists for clinical and research studies
- Pharmacists
- Healthcare executives
- Academic medical centers
- Public health laboratories
- Laboratory technicians
- Anyone planning to implement a predictive genomics program
Webinars will be available for unlimited on-demand viewing after live event.
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.